Fresenius Medical Care KGAA ST (FMEG)

70.14
-0.08(-0.11%)
  • Volume:
    1,414,137
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    69.56 - 70.30

FMEG Overview

Prev. Close
70.22
Day's Range
69.56-70.3
Revenue
17.58B
Open
70.22
52 wk Range
55.18-79.96
EPS
3.86
Volume
1,414,137
Market Cap
20.55B
Dividend (Yield)
1.34
(1.91%)
Average Vol. (3m)
581,838
P/E Ratio
18.17
Beta
0.93
1-Year Change
-7.59%
Shares Outstanding
292,912,773
Next Earnings Date
Jul 30, 2021
What is your sentiment on Fresenius Medical Care KGAA ST?
or
Market is currently closed. Voting is open during market hours.

Fresenius Medical Care KGAA ST News

Fresenius Medical Care KGAA ST Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuySell
SummaryStrong BuyStrong BuyStrong BuyStrong BuyNeutral

Fresenius Medical Care KGAA ST Company Profile

Fresenius Medical Care KGAA ST Company Profile

Employees
124995
Market
Germany

Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of December 31, 2020, it operated 4,092 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Read More
  • Resultats del 2020?
    0
    • shorting
      1
      • test
        0
        • Why the quarterly data are so "old" on this Financial Summary ?
          0
          • near to downtrend triangle
            0
            Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
            Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.